Patient safety rounds in a pediatric tertiary care center

Michael L Rinke1, Karen P Zimmer, Christoph U Lehmann

  • 1Department of Pediatrics, John Hopkins University, Balitimore, USA.

Insights

Pediatric safety rounds effectively identify patient safety issues by engaging staff and leadership. This low-cost intervention improves patient safety in pediatric settings.

Area of Science:

  • Pediatric healthcare quality improvement
  • Patient safety research
  • Healthcare management

Background:

  • Patient safety rounds were introduced in a pediatric tertiary care setting.
  • Analysis included three years of general pediatric safety rounds and nine months of pediatric surgical safety rounds.
  • Completed issues were categorized using Modified Vincent and University HealthSystem Consortium (UHC) schemes.

Purpose of the Study:

  • To analyze completed patient safety issues identified through safety rounds.
  • To compare categorization attributes using two different classification schemes.
  • To evaluate the reception and effectiveness of pediatric safety rounds.

Main Methods:

  • Retrospective analysis of 159 completed patient safety issues from January 2003 to January 2006.
  • Categorization of issues using the Modified Vincent and UHC classification systems.
  • Assessment of staff and executive reception to the safety rounds initiative.

Main Results:

  • The majority of issues (93%) originated from general pediatric safety rounds.
  • UHC scheme: 35.8% care coordination/records, 27.0% equipment safety, 21.4% equipment/supplies/devices.
  • Modified Vincent scheme: 63.5% environmental factors, 23.3% team factors.
  • Pediatric safety rounds were positively received by staff and executives.

Conclusions:

  • Pediatric safety rounds are a valuable, low-cost patient safety improvement tool.
  • The initiative effectively partners senior leadership with frontline staff.
  • This approach enhances patient safety within pediatric healthcare environments.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...